Original language | English |
---|---|
Article number | e408 |
Journal | Blood cancer journal |
Volume | 6 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2016 |
Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
L. Ratner, D. Rauch, H. Abel, B. Caruso, A. Noy, S. K. Barta, S. Parekh, J. C. Ramos, R. Ambinder, A. Phillips, J. Harding, H. H. Baydoun, X. Cheng, S. Jacobson
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Section of Molecular Oncology & Developmental Therapeutics
- Division of Oncology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
Research output: Contribution to journal › Letter › peer-review
32
Scopus
citations